Original Article
Copyright ©2014 Baishideng Publishing Group Inc.
World J Hepatol. Aug 27, 2014; 6(8): 613-620
Published online Aug 27, 2014. doi: 10.4254/wjh.v6.i8.613
Table 1 Clinical and demographic characteristics of non-alcoholic fatty liver disease patients and controls
VariableNAFLD (n = 20)Control (n = 20)P
Age (yr)42.75 ± 8.1744.50 ± 9.310.761
Sex (male/female)9 (45.0)/11(55.0)9 (45.0)/11 (55.0)0.761
BMI (kg/m2)31.86 ± 4.7627.26 ± 3.070.006
Waist circumference (cm)103.25 ± 13.6590.75 ± 11.020.014
Systolic blood pressure (mmHg)120.25 ± 8.66120.25 ± 7.690.999
Diastolic blood pressure (mmHg)76.50 ± 6.0977.50 ± 8.960.761
Fasting glucose (mg/dL)97.85 ± 13.8886.80 ± 11.920.034
Triglycerides (mg/dL)151.10 ± 65.06167.70 ± 51.460.645
HDL-C (mg/dL)43.00 (36.50-48.50)45.00 (38.45-49.95)0.761
LDL-C (mg/dL)125.50 (100.00-139.00)108.00 (89.25-121.25)0.511
Insulin (mIU/mL)14.81 (11.88-22.75)11.76 (8.61-15.70)0.229
HOMA-IR4.05 (2.71-5.51)2.21 (1.77-3.12)0.034
Total biluribin (mg/dL)0.65 (0.50-0.80)0.60 (0.55-0.80)0.761
Direct biluribin (mg/dL)0.20 (0.12-0.25)0.20 (0.10-0.20)0.761
AST (IU/L)45.00 (34.50-59.00)21.00 (18.00-27.00)< 0.001
ALT (IU/L)68.50 (52.50-85.50)18.50 (14.00-29.00)< 0.001
AP (IU/L)76.00 (55.50-96.00)69.00 (57.00-78.50)0.761
GGT (IU/L)48.00 (33.00-73.00)20.00 (14.50-33.00)< 0.001
Creatinine (mg/dL)0.87 ± 0.150.80 ± 0.180.401
WBC (μL)6709.50 ± 1709.476618.00 ± 1425.370.892
Trombocyte (103/μL)252.10 ± 64.85275.90 ± 69.820.511
Hct43.37 ± 3.5344.25 ± 4.190.761